A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial

NCT00580606 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Food Hypersensitivity
Hypersensitivity
Immediate Hypersensitivity
Peanut Hypersensitivity

Interventions

DRUG: Glycerinated peanut allergenic extract
DRUG: Placebo for peanut extract (glycerin)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]